These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 4390121

  • 1. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G, Blum JE, Pletscher A.
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract] [Full Text] [Related]

  • 2. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS, Martin TW.
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract] [Full Text] [Related]

  • 3. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J, Grabowska M, Mogilnicka E.
    Psychopharmacologia; 1971 Apr; 22(2):162-71. PubMed ID: 5124189
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL, Rhodes DL, Yuwiler A.
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract] [Full Text] [Related]

  • 6. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ, Porter CC.
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
    Strömberg U.
    Psychopharmacologia; 1970 Aug 19; 18(1):58-67. PubMed ID: 5535577
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A, Brotchie JM, Jones OT.
    Neurosci Res; 2010 Sep 19; 68(1):44-50. PubMed ID: 20542064
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL, Engel J, Fuxe K.
    Brain Res; 1972 Jun 22; 41(2):387-411. PubMed ID: 4402607
    [No Abstract] [Full Text] [Related]

  • 15. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL, Engel J.
    Brain Res; 1969 Sep 22; 15(1):233-42. PubMed ID: 5807767
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M.
    Acta Pharmacol Toxicol (Copenh); 1969 Sep 22; 27(2):135-48. PubMed ID: 5819569
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO, Seiden LS.
    Physiol Behav; 1971 Mar 22; 6(3):215-7. PubMed ID: 5125476
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.